11.Carini DJ,Ardecky RJ,Ensinger CL,et al.Nonpeptide angiotensinⅡreceptor antagonists: the discovery of DMP581 and DMP811.Bioorg Med Chem Lett, 1994,4(1):63
22.Kubo K,Kohra Y,Yoshimura Y,et al.Nonpeptide angiotensinⅡreceptor antagonists,synthesis and biological activity of potential prodrugs of benzimi-dazole-7-carboxylic acids.J Med Chem,1993,36(22):2343
33.Ries UJ, Mihm G, Narr B, et al.6-Substituted benzimidazoles as new nonpeptide angiotensinⅡreceptor antagonists: synthesis, biological, activity, and structure activity relationships. J Med Chem,1993,36(25):4040
44.Ueyama N,Yanagisawa T,Baba H,et al.Cycloheptimidazoles based angiotensinⅡreceptor antagonists,4,5,6,7-tetrahydro-8-carboxymeth-ylidene cyclohep-timidazoles.Bioorg Med Chem Lett,1994,4(12):1637
55.Bernhart CA,Perreaut Pm,Ferrari BP,et al.A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensinⅡ receptor antagonists,J Med Chem,1993,36(22):3371
66.Levin JI,Chan PS,Coupet J,et al. Synthesis and biological evaluation of the potent isoxazolinyl angiotensinⅡ receptor antagonists CL332877 and its enantiomers. Bioorg Med Chem Lett,1994,4(12):1709
77.John WE,Michael DC,Dominick QG,et al.Metabolites of the angiotensinⅡ receptor antagonists tasosartan:the important of a second acidic group. J Med Chem,1998,41(22):4251
88.Yasuda S, Hui C, Fujishima K, et al. In vivo pharmacological profile of ME3221,a novel angiotensinⅡ(AⅡ)receptor antagonists. Jpn J Pharmacol, 1994, 64(suppl):331P
99.Lloyd J, Ryono DE, Bird JE,et al. Quinolinecarboxylic acids as angiotensinⅡ receptor antagonists. Bioorg Med Chem Lett,1994,4(1):195
1010.Middlemiss D, Watson SP.A medicinal chemistry case study: an account of an angiotensinⅡ receptor antagonists drug discovery programme. Tetrahedron,1994,50(46):13049
